Are blood lipids associated with microvascular complications among type 2 diabetes mellitus patients? A cross-sectional study in Shanghai, China

[1] Gheith O(2016)Diabetic kidney disease: world wide difference of prevalence and risk factors J Nephropharmacol 5 49-56

[2] Farouk N(2003)Diabetic nephropathy Clin Cornerstone 5 1-11

[3] Nampoory N(2011)Epidemiological features of the end-stage renal disease and the application, cost and payment of dialysis care in China Chinese Journal of Health Policy 05 29-33

[4] Halim MA(2012)Global prevalence and major risk factors of diabetic retinopathy Diabetes Care 35 556-564

[5] Al-Otaibi T(2007)Management of diabetic retinopathy: a systematic review JAMA 298 902-916

[6] Rabkin R(2006)Prediction, progression and prevention of diabetic nephropathy. The Minkowski lecture 2005 Diabetologia 49 11-19

[7] Xiao Y(2004)Retinopathy in diabetes Diabetes Care 27 S84-S87

[8] Sui BY(2010)Residual microvascular risk in diabetes: unmet needs and future directions Nat Rev Endocrinol 6 19-25

[9] Zhao K(2010)Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial Lancet 376 419-430

[10] Yau JW(2009)Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial Diabetologia 52 2027-2036

[1] Gheith O(2016)Diabetic kidney disease: world wide difference of prevalence and risk factors J Nephropharmacol 5 49-56

[2] Farouk N(2003)Diabetic nephropathy Clin Cornerstone 5 1-11

[3] Nampoory N(2011)Epidemiological features of the end-stage renal disease and the application, cost and payment of dialysis care in China Chinese Journal of Health Policy 05 29-33

[4] Halim MA(2012)Global prevalence and major risk factors of diabetic retinopathy Diabetes Care 35 556-564

[5] Al-Otaibi T(2007)Management of diabetic retinopathy: a systematic review JAMA 298 902-916

[6] Rabkin R(2006)Prediction, progression and prevention of diabetic nephropathy. The Minkowski lecture 2005 Diabetologia 49 11-19

[7] Xiao Y(2004)Retinopathy in diabetes Diabetes Care 27 S84-S87

[8] Sui BY(2010)Residual microvascular risk in diabetes: unmet needs and future directions Nat Rev Endocrinol 6 19-25

[9] Zhao K(2010)Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial Lancet 376 419-430

[10] Yau JW(2009)Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial Diabetologia 52 2027-2036